DURECT Corp (DRRX), Gilead (GILD) Enter into License Agreement for Long-Acting Injectable HIV Investigational Product

July 22, 2019 8:01 AM

DURECT Corporation (Nasdaq: DRRX) announced today that it has entered into an agreement with Gilead Sciences, Inc. (Nasdaq: GILD) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found